Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Cantargia patents

List of Cantargia patents

List of Tesora patents

List of Pantarhei Bioscience patents

List of Summer Infant patents

List of companies founded by David Krock

List of SBIR/STTR awards granted to Atlas Scientific

Patents where

Current Assignee

Name

is

‌

Cantargia

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11479610 Anti-IL1RAP antibody	Patent 11479610 was granted and assigned to Cantargia on October, 2022 by the United States Patent and Trademark Office.	‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	11479610	October 25, 2022
	‌ US Patent 9796783 Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof	Patent 9796783 was granted and assigned to Cantargia on October, 2017 by the United States Patent and Trademark Office.	‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	9796783	October 24, 2017
	‌ US Patent 11236172 Methods of producing an IL-1 RAP antibodies	Patent 11236172 was granted and assigned to Cantargia on February, 2022 by the United States Patent and Trademark Office.	‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	11236172	February 1, 2022
	‌ US Patent 11359025 Anti-IL1-RAP antibodies	Patent 11359025 was granted and assigned to Cantargia on June, 2022 by the United States Patent and Trademark Office.	‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	11359025	June 14, 2022
	‌ US Patent 10995144 Methods of detecting a solid tumor with anti-IL1RAP antibodies	Patent 10995144 was granted and assigned to Cantargia on May, 2021 by the United States Patent and Trademark Office.	‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	10995144	May 4, 2021
	‌ US Patent 10878703 Method of treatment of leukemia with anti-IL1RAP antibodies		‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	10878703	December 29, 2020
	‌ US Patent 10562971 Method of detection of IL1RAP on cells expressing the protein	Patent 10562971 was granted and assigned to Cantargia on February, 2020 by the United States Patent and Trademark Office.	‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	10562971	February 18, 2020
	‌ US Patent 10100119 Anti-human interleukin-1 receptor accessory protein antibody and its use for treating cancer	Patent 10100119 was granted and assigned to Cantargia on October, 2018 by the United States Patent and Trademark Office.	‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	10100119	October 16, 2018
	‌ US Patent 10287357 Methods of treating cancer using anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies	Patent 10287357 was granted and assigned to Cantargia on May, 2019 by the United States Patent and Trademark Office.	‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	10287357	May 14, 2019
	‌ US Patent 10005842 Method of treatment for leukemia using an anti-IL1RAP antibody	Patent 10005842 was granted and assigned to Cantargia on June, 2018 by the United States Patent and Trademark Office.	‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	10005842	June 26, 2018
	‌ US Patent 9458237 Method for inducing cell death in acute lymphoblastic leukemic system cells	Patent 9458237 was granted and assigned to Cantargia on October, 2016 by the United States Patent and Trademark Office.		‌ Cantargia		United States Patent and Trademark Office	9458237	October 4, 2016
	‌ US Patent 9403906 Method of treatment of a solid tumor with interleukin-1 accessory protein antibody	Patent 9403906 was granted and assigned to Cantargia on August, 2016 by the United States Patent and Trademark Office.		‌ Cantargia		United States Patent and Trademark Office	9403906	August 2, 2016
	‌ US Patent 10005841 Method of treating a solid tumor with IL1RAP antibodies	Patent 10005841 was granted and assigned to Cantargia on June, 2018 by the United States Patent and Trademark Office.	‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	10005841	June 26, 2018
	‌ US Patent 10752692 Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof		‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	10752692	August 25, 2020
	‌ US Patent 11773174 Anti-IL1RAP antibodies and their use for treating humans	Patent 11773174 was granted and assigned to Cantargia on October, 2023 by the United States Patent and Trademark Office.	‌ Cantargia	‌ Cantargia		United States Patent and Trademark Office	11773174	October 3, 2023

15 results

0 selected

15 results

0 selected